Literature DB >> 27957051

Frequent Atrial Fibrillation in CYP2D6 Deficiency.

Harry W Daniell M D1.   

Abstract

Entities:  

Year:  2014        PMID： 27957051      PMCID： PMC4956139          DOI： 10.4022/jafib.1046

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


× No keyword cloud information.
  4 in total

1.  The influence of CYP2D6 polymorphism on the antiarrhythmic efficacy of propafenone in patients with paroxysmal atrial fibrillation during 3 months propafenone prophylactic treatment.

Authors:  E Jazwinska-Tarnawska; K Orzechowska-Juzwenko; P Niewinski; Z Rzemislawska; K Loboz-Grudzien; M Dmochowska-Perz; J Slawin
Journal:  Int J Clin Pharmacol Ther       Date:  2001-07       Impact factor: 1.366

Review 2.  Lone AF - Etiologic Factors and Genetic Insights into Pathophysiolgy.

Authors:  Babar Parvez; Dawood Darbar
Journal:  J Atr Fibrillation       Date:  2010-06-01

3.  Evaluation of CYP2D6 oxidation of dextromethorphan and propafenone in a Chinese population with atrial fibrillation.

Authors:  M S Chow; C M White; C P Lau; C Fan; M O Tang
Journal:  J Clin Pharmacol       Date:  2001-01       Impact factor: 3.126

4.  [Pharmacogenetic study of the response to flecainide and propafenone in patients with atrial fibrillation].

Authors:  Manuel Martínez-Sellés; Isabel Castillo; Pilar Montenegro; María L Martín; Jesús Almendral; María Sanjurjo
Journal:  Rev Esp Cardiol       Date:  2005-06       Impact factor: 4.753
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.